Edition:
United Kingdom

Resverlogix Receives FDA Protocol Acceptance For Ongoing Phase 3 Betonmace Trial


Thursday, 11 Jan 2018 

Jan 11 (Reuters) - Resverlogix Corp ::RESVERLOGIX RECEIVES FDA PROTOCOL ACCEPTANCE FOR THE ONGOING PHASE 3 BETONMACE TRIAL.RESVERLOGIX CORP - BETONMACE TOP LINE DATA IS STILL PLANNED TO BE AVAILABLE AROUND END OF 2018.RESVERLOGIX - BETONMACE TRIAL WILL NOW BE EXPANDED TO NORTH AMERICA. 

Company Quote

3.01
0.0 +0.00%
20 Aug 2019